Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Other Income/Expenses (Net)

-$604.00M

Quarterly · Period ending: · USD

TEVA logo

TEVA Other Income/Expenses (Net)

Latest reported-$604.00M
TEVA Quarterly Other Income/Expenses (Net) (-$22.80M → -$604.00M)
High-resolution chart · PNG

TEVA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-604,000,000
-216,000,000
-209,000,000
-234,000,000
-251,000,000
-225,000,000
-218,000,000
-270,000,000
-239,000,000
-253,000,000
-248,000,000
-280,000,000
-237,000,001
-221,000,001
-245,000,000
-254,000,000
1,589,999,999
-237,000,000
-253,000,000
-244,000,000
-263,000,000
-287,000,000
-223,000,001
19,000,000
-224,000,000
-225,000,000
45,000,000
-211,000,000
-206,000,000
-218,000,000
-223,000,000
-229,000,000
-236,000,000
-271,000,000
-191,000,000
-259,000,000
-238,000,000
-207,000,000
-777,000,000
-150,000,000
-90,000,000
-304,000,000
-70,000,000
-701,000,000
-35,000,000
-201,000,000
-70,000,000
-89,000,000
-78,000,000
-81,000,000
-59,000,000
-83,000,000
-1,599,000,000
-258,000,000
-146,000,000
-1,271,000,000
-97,000,000
-70,000,000
-1,262,000,000
-67,000,000
20,000,000
-38,000,000
-47,000,000
-3,000,000
-148,000,000
-27,000,000
-26,000,000
-52,000,000
-61,000,000
-63,000,000
-296,000,000
63,000,000
-28,000,000
-57,000,000
-3,000,000
-3,000,000
-8,000,000
-28,000,000
3,800,000
-28,100,000
-56,400,000
-14,100,000
-9,800,000
6,800,000
-900,000
-400,000
16,600,000
8,800,000
1,800,000
-1,300,000
9,100,000
-1,200,000
-8,900,000
-4,000,000
-11,200,000
-6,900,000
-2,300,000
-4,300,000
-3,730,000
-2,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.